Physician profile
Barbara Hicks
NPI 1609420231
$1,032.19
in general payments reported to CMS, 2019-2025
17 companies · $76.91 in 2025
The $76.91 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $258 · 2022: $207 · 2023: $314 · 2024: $177 · 2025: $76.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $228.35 | 2021-2024 | Repatha |
| Galderma Laboratories, L.P. | $139.31 | 2021-2024 | Dysport |
| Novo Nordisk INC | $136.67 | 2021-2024 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.72 | 2022-2024 | Jardiance |
| Lilly USA, LLC | $78.06 | 2021-2023 | Mounjaro, Trulicity |
| Novartis Pharmaceuticals Corporation | $70.93 | 2022-2025 | |
| Merz North America, INC. | $42.41 | 2021-2023 | |
| Esperion Therapeutics, INC. | $38.12 | 2023-2025 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.92 | 2023-2024 | Xifaxan |
| Glaxosmithkline, LLC. | $31.38 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.20 | 2023 | |
| Atricure, INC. | $24.91 | 2024 | |
| Sunovion Pharmaceuticals INC. | $22.95 | 2021 | |
| Mylan Specialty L.P. | $18.15 | 2021 | |
| Boston Scientific Corporation | $17.57 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $17.25 | 2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.